健特生物财务报表 |
评论“健特生物” |
|
|
项目 |
2003年 |
2002年 |
2001年 |
货币资金 |
135,731,936.00 |
239,726,832.00 |
143,349,024.00 |
短期投资 |
29,164,132.00 |
0.00 |
0.00 |
减:短期投资跌价准备 |
0.00 |
0.00 |
0.00 |
短期投资净额 |
0.00 |
0.00 |
0.00 |
应收票据 |
78,598,704.00 |
0.00 |
0.00 |
应收股利 |
0.00 |
0.00 |
0.00 |
应收利息 |
0.00 |
0.00 |
0.00 |
应收帐款 |
82,009,648.00 |
34,741,048.00 |
22,395,534.00 |
减:坏帐准备 |
0.00 |
0.00 |
0.00 |
应收帐款净额 |
0.00 |
0.00 |
0.00 |
预付帐款 |
12,881,135.00 |
39,814,504.00 |
2,091,788.75 |
应收补帖款 |
0.00 |
0.00 |
0.00 |
其它应收款 |
24,347,250.00 |
16,602,858.00 |
24,249,226.00 |
存货 |
56,609,560.00 |
62,698,068.00 |
25,306,754.00 |
减:存货跌价准备 |
0.00 |
0.00 |
0.00 |
存货净额 |
56,609,560.00 |
62,698,068.00 |
0.00 |
待摊费用 |
686,179.50 |
481,085.47 |
19,945.07 |
待处理流动资产净损失 |
0.00 |
0.00 |
0.00 |
一年内到期的长期流动资产净损失 |
|
|
|
其它流动资产 |
0.00 |
0.00 |
0.00 |
流动资产合计 |
420,028,544.00 |
394,064,384.00 |
217,412,272.00 |
中长期贷款 |
|
|
|
逾期贷款 |
|
|
|
减贷款呆帐准备 |
|
|
|
长期股权投资 |
144,636,256.00 |
163,402,720.00 |
149,172,384.00 |
长期债权投资 |
0.00 |
0.00 |
0.00 |
长期投资合计 |
144,636,256.00 |
163,402,720.00 |
149,172,384.00 |
减:长期投资减值准备(相当投资风险准备) |
0.00 |
0.00 |
0.00 |
长期投资净额(或长期资产、投资合计) |
0.00 |
0.00 |
0.00 |
固定资产原价 |
176,104,368.00 |
164,703,536.00 |
158,382,736.00 |
减:累计折旧 |
31,928,278.00 |
25,087,016.00 |
18,633,926.00 |
固定资产净值 |
144,176,096.00 |
139,616,512.00 |
139,748,816.00 |
工程物资 |
0.00 |
0.00 |
0.00 |
在建工程 |
0.00 |
6,465,180.50 |
155,000.00 |
固定资产清理 |
0.00 |
0.00 |
0.00 |
待处理固定资产净损失 |
0.00 |
0.00 |
0.00 |
固定资产合计 |
124,326,088.00 |
126,231,696.00 |
120,053,816.00 |
无形资产 |
11,856,080.00 |
12,146,455.00 |
6,304,846.50 |
开办费 |
0.00 |
0.00 |
0.00 |
长期待摊费用 |
0.00 |
268,486.16 |
1,323,889.88 |
其它长期资产 |
0.00 |
0.00 |
0.00 |
无形资产及其它资产合计 |
11,856,080.00 |
12,414,942.00 |
7,628,736.50 |
递延税款借项 |
0.00 |
0.00 |
0.00 |
资产总计 |
700,846,976.00 |
696,113,728.00 |
494,267,200.00 |
短期借款 |
25,820,000.00 |
211,170,000.00 |
76,520,000.00 |
应付票据 |
0.00 |
0.00 |
0.00 |
应付帐款 |
59,018,344.00 |
49,668,596.00 |
17,112,280.00 |
预收帐款 |
0.00 |
0.00 |
1,838,797.25 |
代销商品款 |
0.00 |
0.00 |
0.00 |
应付工资 |
685,361.88 |
260,402.91 |
443,304.09 |
应付福利费 |
-1,425,356.62 |
-1,733,388.75 |
-2,134,344.75 |
应付股利 |
10,500,569.00 |
22,833,246.00 |
12,707,481.00 |
应交税金 |
29,838,470.00 |
16,263,356.00 |
18,728,046.00 |
其他应交款 |
557,913.19 |
305,799.03 |
505,513.91 |
其他应付款 |
14,158,714.00 |
13,869,785.00 |
34,945,324.00 |
预提费用 |
559,552.38 |
267,196.59 |
134,937.56 |
一年内到期的长期负债 |
0.00 |
0.00 |
0.00 |
其他流动负债 |
0.00 |
0.00 |
0.00 |
流动负债合计 |
139,713,568.00 |
312,904,992.00 |
160,801,344.00 |
长期借款 |
0.00 |
0.00 |
0.00 |
应付债券 |
0.00 |
0.00 |
0.00 |
长期应付款 |
0.00 |
0.00 |
0.00 |
住房周转金 |
0.00 |
0.00 |
0.00 |
其他长期负债 |
0.00 |
0.00 |
0.00 |
长期负债合计 |
0.00 |
0.00 |
0.00 |
递延税款贷项 |
0.00 |
0.00 |
0.00 |
负债合计 |
139,713,568.00 |
312,904,992.00 |
160,801,344.00 |
少数股东权益 |
54,141,752.00 |
29,412,250.00 |
110,506,232.00 |
股本 |
314,038,368.00 |
251,230,704.00 |
113,679,048.00 |
资本公积金 |
4,430,829.50 |
4,430,829.50 |
103,331,600.00 |
盈余公积金 |
107,327,864.00 |
59,603,316.00 |
11,016,744.00 |
其中公益金 |
37,470,952.00 |
20,740,190.00 |
4,544,666.00 |
未分配利润 |
81,194,576.00 |
38,531,664.00 |
-5,067,761.00 |
股东权益合计 |
506,991,648.00 |
353,796,512.00 |
222,959,632.00 |
负债和股东权益合计 |
700,846,976.00 |
696,113,728.00 |
494,267,200.00 |
|